David R. Ebsworth, Director at Verona Pharma plc (VRNA), bought 160,000 shares at $1.98 ($317K) on 2023-11-06, disclosed to the SEC on 2023-11-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRNA | BUY | 2024-11-07 | $189K | — | Filing → |
| VRNA | BUY | 2024-08-14 | $103K | — | Filing → |
| VRNA | SELL | 2021-05-05 | $9K | — | Filing → |